The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight lossAnna Secher, Lotte Bjerre Knudsen|Journal of Clinical Investigation|2014Cited by 913
The Discovery and Development of Liraglutide and SemaglutideLotte Bjerre Knudsen, Jesper Lau|Frontiers in Endocrinology|2019Cited by 890
Semaglutide lowers body weight in rodents via distributed neural pathwaysSanaz Gabery, Lotte Bjerre Knudsen|JCI Insight|2020Cited by 664
Different domains of the glucagon and glucagon‐like peptide‐1 receptors provide the critical determinants of ligand selectivityS. Runge, Lotte Bjerre Knudsen, Birgitte S. Wulff et al.|British Journal of Pharmacology|2003Cited by 132
Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic kidney disease through dampening the receptor for advanced glycation end products–induced inflammationKarly C. Sourris, Melinda T. Coughlan, Carlos J. Rosado et al.|Kidney International|2023Cited by 121